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A B S T R A C T
Objectives: Methicillin-resistant Staphylococcus aureus (MRSA) causes hospital- and community-acquired
infections. It is not clear whether genetic characteristics of the bacteria contribute to disease
pathogenesis in MRSA infection. We hypothesized that whole genome analysis of MRSA strains could
reveal the key gene loci and/or the gene mutations that affect clinical manifestations of MRSA infection.
Methods: Whole genome sequences (WGS) of MRSA of 154 strains were analyzed with respect to clinical
manifestations and data. Further, we evaluated the association between clinical manifestations in MRSA
infection and genomic information.
Results: WGS revealed gene mutations that correlated with clinical manifestations of MRSA infection.
Moreover, 12 mutations were selected as important mutations by Random Forest analysis. Cluster
analysis revealed strains associated with a high frequency of bloodstream infection (BSI). Twenty seven
out of 34 strains in this cluster caused BSI. These strains were all positive for collagen adhesion gene (cna)
and have mutations in the locus, those were selected by Random Forest analysis. Univariate and
multivariate analysis revealed that these gene mutations were the predictor for the incidence of BSI.
Interestingly, mutant CNA protein showed lower attachment ability to collagen, suggesting that the
mutant protein might contribute to the dissemination of bacteria.
Conclusions: These findings suggest that the bacterial genotype affects the clinical characteristics of MRSA
infection.
© 2019 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Methicillin-resistant Staphylococcus aureus (MRSA) is a com-
mon pathogenic bacterium that causes nosocomial and commu-
nity-acquired infections. An annual report of a nationwide survey
in Japan revealed MRSA was detected at 100% of the hospitals in
2017 (JANIS, 2019). Moreover, MRSA infection can cause severe
illness not only in immunocompromised patients but also in
healthy people. Although anti-MRSA therapeutic agents are
clinically available, MRSA infection can be life threatening.
Whole genome sequencing (WGS) provides robust genetic
identification of bacteria (Köser et al., 2012a). WGS reveals single-
nucleotide polymorphisms (SNPs) and insertions/deletions
(indels), allowing phylogeny tracing of MRSA outbreaks (Harris
et al., 2013; Harris et al., 2010; Köser et al., 2012b). Moreover, a
recent study raised the possibility that genome sequence could
predict the virulence in MRSA (Laabei et al., 2014).
We hypothesized that whole genome analysis could reveal key
gene loci and/or mutations that have an impact on the clinical
manifestations of MRSA infection. To explore this possibility, we
performed whole genome analysis of MRSA with a focus on genes
related to the toxins, drug resistance, and adhesion/biofilm
formation of the bacteria. We compared the clinical features of
infection in clusters based on the similarity of SNPs and indels.
Subjects and methods
Patient characteristics
The baseline clinical data were collected before MRSA infection
or at the same time as isolation of the bacteria. The laboratory data
during MRSA infection were collected from the patients who were
treated with anti-MRSA antibiotics. Performance status (PS) was
graded with the score developed by the Eastern Cooperative
Oncology Group. Vancomycin, teicoplanin, arbekacin, daptomycin,
and linezolid were considered to be anti-MRSA antibiotics.
Bacterial isolation and identification
The MRSA strains were isolated from patients who were
admitted to Kanazawa University Hospital from 1998 to 2015.
MRSA was identified according to colony morphology on mannitol
salt sugar with egg yolk agar, Gram staining, and detection of
coagulase production by the Staphyslide test (Eiken Chemical Co.,
Ltd., Tokyo, Japan).
Biofilm formation assay
Biofilm formation was investigated using the microtiter plate
biofilm assay as described previously (Cassat et al., 2014). Briefly,
diluted bacteria were incubated overnight on 96-well plates
(Corning, NY) or collagen-I coated 96-well plates (Corning, NY).
The attached bacteria were fixed in 100% ethanol and stained with
crystal violet after aspiration of bacterial cultures. The absorbance
of the cultures was read at a wavelength of 595 nm.
DNA sequencing and analysis
DNA was isolated from each MRSA strain using the Nucleo Spin
Tissue kit (MACHREY-NAGEL, Düren) according to the manufac-
turer’s protocol. WGS data from Hiseq sequencing system
(Illumina, San Diego, CA, USA) was generated from 1 mg of DNA
isolated from the bacteria. Extracted DNA was fragmented using
Covaris S220 (Covaris, Woburn, MA, USA). Fragmented DNA was
purified using Agencourt AMPure XP (Beckman Coulter, Inc. Brea,
CA, USA). DNA libraries were constructed using the TruSeq DNA HTSample Prep Kit (Illumina) according to the manufacturer’s
protocol. Constructed DNA libraries were analyzed using an
Agilent Bioanalyzer with the High Sensitivity Kit (Agilent, Santa
Clara, CA, USA). The sequenced data were aligned to a reference
isolate (HO 5096 0412) using Bowtie 2 (http://bowtie-bio.
sourceforge.net/bowtie2/index.shtml) and SAM tools (http://sam-
tools.sourceforge.net/). Then, SNPs and indels were detected with
VarScan (http://varscan.sourceforge.net/). Clustering was per-
formed using Cluster 3.0 (http://bonsai.hgc.jp/mdehoon/soft-
ware/cluster/software.htm) based on the similarity of whole
genome sequences. The domains of amino acid replacements
were detected using the database InterPro (http://www.ebi.ac.uk/
interpro/). All the sequence data are available from the DDBJ
database (accession number DRA006521.)
Preparation of CNA Protein
Preparation of CNA proteins with/without mutation were
prepared as described before (Matsumura et al., 2015; Zong
et al., 2005). Briefly, purified DNA from MRSA strains with/without
can mutation were used as a template for the amplification of DNA
encoding CNA by PCR. The amplified DNAs were inserted into pET-
28b(+) (Merck Millipore). Recombinant CNAs were expressed in E.
coli strain Rosetta2 (Merck Millipore) and purified using HisTrap
HP (GE Healthcare). The purity of CNA proteins were confirmed by
SDS–PAGE (Supplementary Figure S2). Primer sets are listed in
Supplementary Table S1.
Binding assay (enzyme-linked immunosorbent assay, ELISA)
The 96-well plates (IWAKI) were coated with type I collagen
(1.0 mg/well) from calf skin (Sigma-Aldrich) or rat tail for overnight
at 4 C. The wells were washed with phosphate-buffered saline
(PBS) containing 0.05% Tween20 (Sigma-Aldrich) (PBS-T) and
blocked with 1.0% bovine serum albumin (BSA, Sigma-Aldrich)/
PBS-T for overnight at 4 C. CNA proteins were added to a well and
incubated for 1 h at 37 C. After washing, anti-His tag antibody
(MBL) was added and incubated for 1 h at 37 C. After washing,
anti–mouse IgG conjugated with HRP (Jackson ImmunoResearch)
was added and incubated for 1 h at 37 C. Plates were washed again
and then incubated with substrate solution (ABTS, Roche) for 20
min at 37 C, and absorbance values at Abs405 were measured. To
analyze the binding of CNA with type I collagen from pig tendon,
we used collagen coated plate (IWAKI). CNA proteins were added to
plates, and the binding CNA proteins were detected with anti-His
tag antibody and anti–mouse IgG conjugated with HRP.
RNA isolation and quantitative real-time PCR
Total RNA was isolated from fresh overnight cultures of MRSA
strains using the High Pure RNA Isolation Kit (Roche Diagnostics,
Tokyo, Japan). Quantitative real-time polymerase chain reaction
(PCR) based on SYBR Green fluorescence (Bio-Rad, Tokyo, Japan)
was performed on the Villa 7 Real-Time PCR System (Thermo
Fisher Scientific, Tokyo, Japan). The sequences of primers are listed
in Supplementary Table S1. Data were analysed by the delta-delta
Ct method. Primer sets are listed in Supplementary Table S1.
Statistics
Data were presented as the mean  SEM as determined with
StatView software. The data of patients and bacterial strains were
compared with chi-squared test, Fisher exact test, unpaired t-test,
Kruskal–Wallis test as appropriate. Random Forest analysis was
performed with Random Forest package in R (https://www.r-
project.org/). Univariate and multivariate logistic regression
Table 1
The correlation between gene mutation and disease onset in MRSA infection.
Blue columns indicate adhesion/biofilm related genes and green column indicates resistant gene. Closed circle indicates
the mutations, those were raised as important mutations by Random Forest analysis.
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bloodstream infection (BSI).
Ethics statement
Informed consent was obtained from all subjects. All data
analyzed were anonymized. All experiments were performed in
accordance with approved guidelines of Kanazawa University. This
study was conducted with the approval of the ethics committee of
Kanazawa University (IRB approval number:1522).
Results
Adhesion and biofilm-related gene mutations are associated with
disease manifestation in MRSA infection
WGS identified 136686 indels/SNPs from 154 isolated MRSA.
We excluded the mutations in the loci, those encoded putative,
hypothetical or no protein. Totally, 39712 mutations were analyzed
in this study. We explored the relationship between indels/SNPs
and disease manifestations in MRSA infection. Each gene mutation
was evaluated for correlations with infectious disease onset/
bacterial colonization. The correlation coefficients for these
manifestations were then added. The top 54 mutations, which
showed fifth highest correlation coefficient, are listed in Table 1.
The gene mutation 2591486:T->C in the fnbA locus showed the
highest correlation with infectious disease onset. There were 13
indels/SNPs detected in loci related to adhesion and biofilm
formation, while one SNP was detected in the drug-resistance
locus. None were in a toxin-related locus. These data indicate that
mutations in the genes related to adhesion/biofilm formation may
contribute to disease manifestation in MRSA infection.
Twelve mutations were raised as important mutations for infectious
disease onset of MRSA with Random Forest model
The top 1000 mutations, which showed high correlation with
clinical manifestation, were analyzed with Random Forest regres-
sion model. The importance of 30 out of 1000 mutations were
predicted in the model (Figure 1a). To better characterize this
approach, the appearance in the top 30 important mutations was
analyzed as a frequency by repeating the performance 20 times.Figure 1. Random Forest analysis revealed 12 important mutations for infectious disea
Top 1000 mutations, which showed high correlation with clinical manifestation, were an
predicted in the model (a). To better characterize this approach, the appearance in the top
20 times. Two hundred mutations were raised as candidates of important mutations in th
30 important mutations with Random Forest. Thus, these 12 of 1000 mutations were tTwo hundred mutations were raised as candidates of important
mutations in this method (Figure 1b). Among them, 12 mutations
showed over 50 % of appearance in the top 30 important mutations
with Random Forest. Moreover, 6 of 12 mutations were also listed
in the top 54 mutations; those showed high correlation (Table 1).
Thus, these 12 were thought to be important for infectious disease
onset of MRSA.
Cluster analysis of 154 MRSA strains
WGS was used to arrange 154 strains into clusters according to
SNPs and indels. Three strains had patterns of SNPs and indels that
differed from the other 151 strains (Figure 2). We then examined 12
mutations; those were selected by Random Forest analysis in the
cluster. Almost all the strains in cluster C possessed these 12
mutations. Of these mutations, 2810892:T → C at collagen adhe-
sion gene (cna) locus, showed different expression patterns in each
cluster. Interestingly, the presence/absence patterns of the cna
locus matched the WGS cluster pattern. Therefore, we designated
clusters positive for the cna locus as clusters A (n = 18) and C
(n = 34) and those negative for the cna locus as clusters B (n = 76)
and D (n = 23) (Figure 2). ITS genotype (Fujita et al., 2005), the
culture specimen and the wards of the patients in each cluster are
described in Supplementary Figure S1.
Baseline characteristics of patients in each cluster
To compare host factors between clusters, the basal character-
istics of patients were evaluated in each cluster as shown in Table 2.
The patients in cluster A were younger than those in the other
clusters (age [years], cluster A, 44.7  7.3; B, 63.5  2.3; C,
62.6  3.3; D, 66.3  3.0). Performance status was higher in cluster
A than the other clusters (cluster A, 0.6  0.3; B, 2.0  0.3; C,
1.7  0.3; D, 2.4  0.4). Serum albumin levels in cluster B patients
were lower than those in other clusters (cluster A, 3.5  0.2; B,
2.9  0.1; C, 3.2  0.2; D, 3.1 0.2). The other parameters did not
differ between the clusters.
Clinical features of patients in each cluster
To evaluate the clinical impact of the genetic differences
between strains, patient clinical manifestations were comparedse onset.
alyzed with Random Forest regression model. The importance of 30 mutations was
 30 important mutations was analyzed as a frequency by repeating the performance
is method (b). Among them,12 mutations showed over 50 % of appearance in the top
hought to be important for infectious disease onset of MRSA.
Figure 2. Phylogenetic clustering of MRSA.
Whole genome sequencing divided 154 strains into some clusters according to SNPs and indels. Three strains had different patterns of SNPs and indels from 151 strains. We
then examined 12 mutations, selected by Random Forest analysis, in the cluster. Almost all the strains in cluster C possessed these 12 mutations. Of these mutations, 2810892:
T → C at cna locus showed a different expression patterns in each cluster. The present/absent patterns of cna locus matched the cluster pattern of the whole genome sequence.
Thus, we designated the clusters that were positive cna locus as clusters A and C, and the clusters that were negative cna locus as clusters B and D. Gray box shows the strains
that caused BSI.
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patients than that in the other cluster patients (Figures 2 and 3). In
particular, catheter infection was the leading cause of BSI in cluster
C patients. The percentages of patients needing treatment with
anti-MRSA antibiotics and of deceased patients were similar in
each cluster (Figure 3).Laboratory data during infection in each cluster
To compare the severity of infection, we analyzed the
laboratory data acquired during therapy with anti-MRSA anti-
biotics from all surviving patients. The platelet counts were lower
in cluster C patients during the therapy (platelet count  104/mL:
Table 2
The character of patients before MRSA infection.
A B C D
Male/female 10/8 50/26 21/13 17/6
Age 44.7  7.3abc 63.5  2.3 62.6  3.3 66.3  3.0
Ptients on dialysis 1 2 2 0
Performance status 0.6  0.3abc 2.0  0.3 1.7  0.3 2.4  0.4
Platelets (104/mL) 22.8  2.9 25.8  1.4 20.4  1.4 19.7  2.1
Creatinine (mg/dL) 0.8  0.2 1.1  0.2 1.1  0.2 0.7  0.1
T. bilirubin (mg/dL) 0.5  0.1 0.8  0.1 2.4  0.4 1.9  0.7
T. protein (mg/dL) 6.5  0.2 6.2  0.1 6.4  0.3 6.4  0.2
Albumin (g/dL) 3.5  0.2a 2.9  0.1 3.2  0.1 3.1  0.2
Superscripts mean significance (p < 0.05), a: A vs. B, b: A vs. C, c: A vs. D. T; total.
Figure 3. Clinical features of the patients in each cluster.
Clinical manifestations of the patients were investigated in each cluster. Notably, the rate of BSI was higher in cluster C patients than those in cluster A, B and D. Especially,
catheter infection is the leading cause of BSI in patients of cluster C. The percentage of the patients needing treatment with anti MRSA agents and the rate of all-cause of death
were similar among the clusters.
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incidence of AKI and the change of total bilirubin were similar in
the 4 groups (Figure 4).
Bacterial characteristics in each cluster
While both cluster A and C strains had the cna locus, they
exhibited different clinical manifestations. We hypothesized thatthe differencein the cna locus between clustersA and C might be one
reason for clinical difference. Thus, we next investigated bacterial
characteristics, focusing on the cna locus. WGS revealed 17 specific
SNPs at the cna locus, all of which were present in cluster C strains
but not in cluster A strains (Figure 5a). Ten out of 17 SNPs had
changes in the predictable cna amino acid sequence. Moreover, 7
amino acid replacements were located in the functional domain,
and some were accumulated in close site (Figure 5b).
CV. catheter and cna mutations were predictors for BSI
Next, we explored whether these mutations at cna loci were a
predictor for the incidence of BSI. Univariate logistic analysisshowed that CV catheter insertion (hazard ratio [HR], 9.35; 95%
confidence interval [95% CI], 3.948–22.116; p < 0.0001), platelet
counts (HR, 0.96; 95% CI, 0.924–0.995; p = 0.021) and mutation at
cna loci (HR, 7.7; 95% CI, 2.730–21.693; p < 0.0001) were predictors
of BSI. Multivariate analysis revealed that CV catheter insertion
(HR, 5.01; 95% CI, 1.710–15.080; p = 0.003) and mutation at cna loci
(HR, 5.1; 95% CI, 1.442–19.620; p = 0.009) were high risk for BSI
(Table 3).
Figure 4. Laboratory data during infection in each cluster.
To compare the severity of infection, we analyzed the laboratory data acquired during therapy with anti MRSA agents from all surviving patients. The platelet counts were
lower in cluster C patients during the therapy (platelet count  104/mL: cluster C, before infection 21.7  1.7; after infection, 16.0  1.7). The incidence of AKI and the change of
total bilirubin were similar in the 4 groups (Figure 3). Cr; creatinine, T-bil; total bilirubin.
Figure 5. The characteristics of cna locus in cluster A and C.
WGS revealed 17 specific SNPs on cna locus that exist in all of the cluster C strains (a). Ten out of 17 SNPs changed the predictable amino acid sequence of the cna protein.
Moreover, 7 amino acid replacements were located on the functional domain and some of them were observed at close site in cna (b). The domains of amino acid replacements
were detected with InterPro (http://www.ebi.ac.uk/interpro/).
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Table 3
Univariate and multivariate logistic analysis of predictors associated with BSI.
Univariate analysis Multivariate analysis
Hazard ratio 95% C.I. P-value Hazard ratio 95% C.I. P-value
Age (yrs) 1.01 0.997–1.035 0.084
Peformance status 1.19 0.970–1.457 0.094
Diabetes 1.66 0.652–4.249 0.283
CV catheter 9.35 3.948–22.116 <0.0001 5.01 1.710–15.080 0.003
Platelets (104/mL) 0.96 0.924–0.995 0.021 0.95 0.900–1.014 0.1
Creatinine (mg/dL) 0.95 0.731–1.247 0.731
T. bilirubin (mg/dL) 1.1 0.901–1.347 0.322
Albumin (g/dL) 0.72 0.380–1.347 0.296
Cna mutation 7.7 2.730–21.693 <0.0001 5.1 1.442–19.260 0.009
Abbreviations are CV; central venous, T; total, C.I.; confidence interval.
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To evaluate the functional impact of mutant CNA, we performed
an attachment assay of CNA protein to collagen. Surprisingly,
mutant CNA showed lower attachment ability to the collagen from
calf skin, pig tendon and rat tail as compared to CNA without
mutation (Figure 6a). Even at the different concentrations, the
attached CNA to collagen was less as compared to CNA without
mutation (Figure 6b). Recent data showed the biofilm develop-
ment consists of some stages such as bacterial multiplication and
exodus (Moormeier et al., 2014). In particular, the exodus of
bacteria allows for further dissemination of bacterial cells,
resulting in probable severe infection. Thus, we assessed the
exodus stages during biofilm formation on the strains with/
without cna mutation. The strains with cna mutant exhibited a
higher ratio of detached/attached bacteria in the early stage of
biofilm formation, indicating more bacterial dissemination as
compared to the strains without cna mutation (Figure 6c).
Nevertheless, the biofilm formation showed similar levels between
the strains at 24 h. The ratio of detached/attached bacteria in the
early stage of biofilm formation was also higher in the strains with
cna mutant on collagen-I coated plate (Figure 6d). To elucidate
whether CNA contributes to the early stage of biofilm develop-
ment, the gene expressions of the adhesion/biofilm formation
related molecules were evaluated. The expression level of cna was
higher at 4 to 8 h of biofilm formation. Interestingly, the expression
levels of cna is lower in cna mutant strain as compared to non-
mutant strain (Figure 6e). Some other molecules, such as icaA, icaB,
icaC, icaR, eno, and fnbA also showed increased expression at the
early stage of biofilm development. While the expression levels of
some genes were decreased at 12 and 24 h in the non-mutant
strain, the expression levels of genes such as icaA, icaB, icaC, icaD,
icaR, sarS, sdrD, dltD and fnbA, remained at high levels in the mutant
strain (Figure 6e). Next, the gene mutation in the functional
domain of these molecules was analyzed to see if gene mutation
could contribute to changing the function of the molecules. The
frequency of mutation in the functional domain is relatively high in
the functional domain in the cna locus (Figure 6f).
Discussion
We observed that the mutations in the cna locus have an impact
on the clinical manifestations of MRSA infection. Gene mutations
in loci associated with adhesion and biofilm formation correlated
with disease onset/bacterial colonization in MRSA infection. The
profiles of SNPs and indels divided the MRSA strains into several
clusters that matched the pattern of the presence/absence of the
cna locus. The frequency of BSI, especially catheter infection, was
higher in the cluster in which the cna locus was present.
Interestingly, several specific gene mutations and amino acid
substitutions were detected in the cna gene in cluster C strains.Moreover, mutation in the cna locus as well as CV catheter
insertion were the predictors for the incidence of BSI. Interestingly,
mutant CNA protein showed lower attachment ability to collagen,
suggesting that mutant CNA might contribute to the exodus of
bacteria and the dissemination of infection.
WGS provides sufficient discriminatory genomic information to
identify bacterial lineages. Several studies have reported the use of
WGS to trace the path of MRSA hospital outbreaks (Harris et al.,
2013; Harris et al., 2010; Köser et al., 2012b). In addition, WGS has
been used to elucidate the genetic pathogenesis of resistance to
antibiotics (Alm et al., 2014; Leopold et al., 2014; Iwata et al., 2017).
Another group has reported that WGS revealed the insertion of
gene loci from a close relative MRSA strain, resulting in the de-
repression of cytotoxin expression and increased virulence
(Benson et al., 2014). In our study, whole genome analysis revealed
that specific strains are more likely to cause BSI. Since there was no
difference in host factors except the younger age with high PS in
cluster A and lower albumin levels in cluster B, these differences in
clinical manifestation could be attributable to MRSA genotype
differences.
Several groups have explored the relationship between MRSA
genotype characteristics and BSI. Xiong et al. (2009a) reported that
persistent MRSA bacteremia isolates had a higher frequency of
several drug resistance genes. van der Mee-Marquet et al. (2004)
demonstrated clonal diffusion of the 3 major French MRSA clones
among patients with BSI using pulsed-field gel electrophoresis.
Other studies determined the genotypes of bacteremia isolates
from patients with liver disease (Török et al., 2014) and kidney
disease (McNicholas et al., 2011). While these studies showed the
genotypic diversity of MRSA in BSI, limited data are available
regarding whether certain genotypic lineages are more likely to
cause BSI.
Recent studies employed logistic prediction analysis, such as
Random Forest, to model the genetic risk to some diseases (Zhen
et al., 2017; Chuang and Kuo, 2017), including MRSA infection
(Laabei et al., 2014). Twelve mutations of top 1000 mutations,
which showed high correlation with MRSA infection, were raised
as important mutations in this study. Of these mutations, 2810892:
T → C at cna locus, showed different expression patterns in each
cluster. Interestingly, the presence/absence patterns of the cna
locus matched the WGS cluster pattern.
The cluster C strain that was associated with a higher frequency
of BSI had the cna locus. Cna is a cell-wall-anchored protein that
contributes to the adhesion to collagen-rich tissue (Foster et al.,
2014). A recent study revealed that cna inhibits the activation of
the complement system by binding to C1q (Kang et al., 2013). An
association between the cna locus and BSI has been reported in
several studies. Persistent bacteremia isolates exhibited a higher
frequency of bearing cna than that in resolving bacteremia isolates
(Xiong et al., 2009b). Clusters that were positive for the cna locus
were observed in 50% of BSI cases (Yu et al., 2012) and 71% of
Figure 6. The functional assay of CNA protein.
The attachment ability of CNA proteins with/without mutation were evaluated using various types of collagen. Mutant CNA showed lower attachment ability to collagen as
compared to without mutation (a). Even at different concentrations, the attached CNA to collagen was less as compared to CNA without mutation (b). The attachment/ biofilm
assay showed that the exodus on early stage of biofilm development is increased in cna mutant strains as compared to the strains without cna mutation on non-coated plate
(c) as well as collagen coated plate (d). The gene expression of cna was up-regulated at an early time point during the biofilm formation. Moreover, the expression levels of cna
were lower in cna mutant strain as compared to non-mutant strain (d). The frequency of mutations on the functional domain in each locus (e).
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aureus. Blomfeldt A. et al. reported S. aureus clonal complex 30
genotype was associated with mortality in patients with BSI
(Blomfeldt et al., 2016). Moreover, S. aureus clonal complex 30 has
been reported to possess cna locus (Nienaber et al., 2011). These
reports showed the association of cna locus with high incidence of
BSI with/without high mortality.
Although the cluster A strain has the cna locus, the frequency of
BSI was lower in cluster A than that in cluster C patients. This
observation could result from differences of the cna locus between
bacteria in clusters A and C. To explore the possibility, we nextinvestigated bacterial characteristics related to the cna locus. The
cluster C strain had several specific gene mutations and showed
amino acid replacements that would affect the predicted structure
of the cna protein. These results indicate that the specific gene
mutations may change the cna protein structure, thereby
modifying its function in the cluster C strain.
Univariate and multivariate analysis also revealed that cna
mutation was an independent predictor for the incidence of BSI.
Surprisingly, hazard ratio of cna mutations is almost same as that of
CV catheter insertion. This result may suggest that the MRSA strain
carrying cna mutations has a high impact for BSI. However, more
Y. Iwata et al. / International Journal of Infectious Diseases 91 (2020) 22–31 31analysis, including prospective cohort study, is needed to clarify
the risk for BSI of the strain.
Interestingly, the attachment ability to collagen is lower in
mutant CNA as compared to that without mutation. Recent study
revealed that detachment in the early phase of biofilm formation
causes the dissemination of bacteria and allows for possible
expansion of infection (Moormeier et al., 2014). In this regard, the
strains with mutant cna showed a higher ratio of detached and
attached bacterial numbers as compared to normal strain,
especially in the early phase of biofilm formation. Moreover, the
gene expression of cna was increased at the early time point of
biofilm formation, which suggests that cna might contribute to the
exodus of bacteria. In addition, the expression level of cna was
lower in cna mutant strain as compared to non-mutant strain,
which would indicate that not only the function of CNA but also the
low expression levels of CNA might decrease the attachment ability
in the cna mutant strain. Some other molecules, such as icaA, icaR,
fnbA, sdrD, AgrA and SarS also showed increased expression at the
early stage of biofilm development. However, the frequency of
gene mutation on functional domain is higher in cna as compared
to the other molecules, suggesting that the mutation of CNA might
be associated with the exodus of bacteria in the early phase of
biofilm formation. However, more precise studies are needed to
clarify the contribution of gene mutation to biofilm formation,
especially exodus of bacteria.
In summary, WGS revealed a cluster of MRSA patients with a
high frequency of BSI and infection by strains with a mutation in
the cna locus. These findings suggest that the bacterial genotype
affects the clinical characteristics of MRSA infection. In particular,
patients with strains carrying cna mutations could have an
increased risk of BSI.
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